Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.

Gao Z, Yan H, Feng X, Wu L, Qiu M, Xing W, Zhang G, Zhang Z, Jiang Y.

PLoS One. 2016 Aug 11;11(8):e0161183. doi: 10.1371/journal.pone.0161183. eCollection 2016.

2.

Estimating HIV incidence among key affected populations in China from serial cross-sectional surveys in 2010-2014.

Cui Y, Guo W, Li D, Wang L, Shi CX, Brookmeyer R, Detels R, Ge L, Ding Z, Wu Z.

J Int AIDS Soc. 2016 Mar 16;19(1):20609. doi: 10.7448/IAS.19.1.20609. eCollection 2016.

3.

Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.

Romero-Severson EO, Lee Petrie C, Ionides E, Albert J, Leitner T.

Int J Epidemiol. 2015 Jun;44(3):998-1006. doi: 10.1093/ije/dyv034. Epub 2015 Jul 10.

4.

Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Duong YT, Kassanjee R, Welte A, Morgan M, De A, Dobbs T, Rottinghaus E, Nkengasong J, Curlin ME, Kittinunvorakoon C, Raengsakulrach B, Martin M, Choopanya K, Vanichseni S, Jiang Y, Qiu M, Yu H, Hao Y, Shah N, Le LV, Kim AA, Nguyen TA, Ampofo W, Parekh BS.

PLoS One. 2015 Feb 24;10(2):e0114947. doi: 10.1371/journal.pone.0114947. eCollection 2015.

5.

Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.

Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C.

PLoS One. 2014 Jun 3;9(6):e98038. doi: 10.1371/journal.pone.0098038. eCollection 2014.

6.

Development of a proficiency testing program for the HIV-1 BED incidence assay in China.

Yan H, Yu H, Xing W, Xiao Y, Zhang H, Pei L, Zhang N, Jiang Y.

Sci Rep. 2014 Mar 28;4:4512. doi: 10.1038/srep04512.

7.

Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.

Drake AL, Wagner A, Richardson B, John-Stewart G.

PLoS Med. 2014 Feb 25;11(2):e1001608. doi: 10.1371/journal.pmed.1001608. eCollection 2014 Feb. Review.

8.

Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.

Schüpbach J, Bisset LR, Gebhardt MD, Regenass S, Bürgisser P, Gorgievski M, Klimkait T, Andreutti C, Martinetti G, Niederhauser C, Yerly S, Pfister S, Schultze D, Brandenberger M, Schöni-Affolter F, Scherrer AU, Günthard HF; Swiss HIV Cohort Study.

BMC Infect Dis. 2012 Apr 12;12:88. doi: 10.1186/1471-2334-12-88.

9.

Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, Nkengasong JN, Parekh BS.

PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.

10.

A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.

Dobbs T, Liu X, Anderson R, Nkengasong J, Parekh BS.

J Clin Microbiol. 2011 Oct;49(10):3470-3. doi: 10.1128/JCM.01122-11. Epub 2011 Aug 10.

11.

Current and future assays for identifying recent HIV infections at the population level.

Smoleń-Dzirba J, Wąsik TJ.

Med Sci Monit. 2011 May;17(5):RA124-33. Review.

12.

Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods.

Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, Bunnell R, Hargrove J, Mermin J, Kaiser RK, Barsigo A, Ghys PD.

PLoS One. 2011 Mar 7;6(3):e17535. doi: 10.1371/journal.pone.0017535.

Items per page

Supplemental Content

Write to the Help Desk